Cargando…

Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections

The purpose of this study was to determine whether acute pulmonary exacerbations of cystic fibrosis associated with nonbacterial infections are clinically distinguishable from other exacerbations. Eighty exacerbations in 54 patients were studied. Exacerbations associated with influenza (n=8) were co...

Descripción completa

Detalles Bibliográficos
Autores principales: Pribble, Charles G., Black, Philip G., Bosso, John A., Turner, Ronald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130847/
https://www.ncbi.nlm.nih.gov/pubmed/2380817
http://dx.doi.org/10.1016/S0022-3476(05)80530-X
_version_ 1783517103731507200
author Pribble, Charles G.
Black, Philip G.
Bosso, John A.
Turner, Ronald B.
author_facet Pribble, Charles G.
Black, Philip G.
Bosso, John A.
Turner, Ronald B.
author_sort Pribble, Charles G.
collection PubMed
description The purpose of this study was to determine whether acute pulmonary exacerbations of cystic fibrosis associated with nonbacterial infections are clinically distinguishable from other exacerbations. Eighty exacerbations in 54 patients were studied. Exacerbations associated with influenza (n=8) were compared with those associated with other nonbacterial infections (n=15) and those in which no nonbacterial infection was detected (n=57). Patients with influenza had lower Shwachman scores and were more likely to be seroposifive for C-reactive protein than patients in the other two groups. Patients with influenza had lower Shwachman scores and were more likely to be seropositive for C-reactive protein than patients in the other two groups. Patients with influenza had a mean decrease in forced expiratory volume per second of 26%, compared with test results obtained before the exacerbation. In contrast, the mean decrease in forced expiratory volume per second was 6% for other nonbacterial infections and 12% for the group without nonbacterial infection (p<0.05 for both comparisons). The forced expiratory flow in first 25% of vital capacity decreased 44% in the influenza group compared with 13% and 17% in the other two groups, respectively (p<0.01 for both comparisons). The influenza group also had a higher proportion of patients with at least a 20% decrease in forced expiratory volume per second and forced expiratory flow in first 25% of vital capacity than the other two groups had (p<0.05 for all comparisons). These data suggest that influenza is associated with severe exacerbations in patients with cystic fibrosis and support recommendations for efforts to prevent influenza in this population.
format Online
Article
Text
id pubmed-7130847
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71308472020-04-08 Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections Pribble, Charles G. Black, Philip G. Bosso, John A. Turner, Ronald B. J Pediatr Article The purpose of this study was to determine whether acute pulmonary exacerbations of cystic fibrosis associated with nonbacterial infections are clinically distinguishable from other exacerbations. Eighty exacerbations in 54 patients were studied. Exacerbations associated with influenza (n=8) were compared with those associated with other nonbacterial infections (n=15) and those in which no nonbacterial infection was detected (n=57). Patients with influenza had lower Shwachman scores and were more likely to be seroposifive for C-reactive protein than patients in the other two groups. Patients with influenza had lower Shwachman scores and were more likely to be seropositive for C-reactive protein than patients in the other two groups. Patients with influenza had a mean decrease in forced expiratory volume per second of 26%, compared with test results obtained before the exacerbation. In contrast, the mean decrease in forced expiratory volume per second was 6% for other nonbacterial infections and 12% for the group without nonbacterial infection (p<0.05 for both comparisons). The forced expiratory flow in first 25% of vital capacity decreased 44% in the influenza group compared with 13% and 17% in the other two groups, respectively (p<0.01 for both comparisons). The influenza group also had a higher proportion of patients with at least a 20% decrease in forced expiratory volume per second and forced expiratory flow in first 25% of vital capacity than the other two groups had (p<0.05 for all comparisons). These data suggest that influenza is associated with severe exacerbations in patients with cystic fibrosis and support recommendations for efforts to prevent influenza in this population. Published by Mosby, Inc. 1990-08 2006-03-02 /pmc/articles/PMC7130847/ /pubmed/2380817 http://dx.doi.org/10.1016/S0022-3476(05)80530-X Text en Copyright © 1990 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pribble, Charles G.
Black, Philip G.
Bosso, John A.
Turner, Ronald B.
Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
title Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
title_full Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
title_fullStr Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
title_full_unstemmed Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
title_short Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
title_sort clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130847/
https://www.ncbi.nlm.nih.gov/pubmed/2380817
http://dx.doi.org/10.1016/S0022-3476(05)80530-X
work_keys_str_mv AT pribblecharlesg clinicalmanifestationsofexacerbationsofcysticfibrosisassociatedwithnonbacterialinfections
AT blackphilipg clinicalmanifestationsofexacerbationsofcysticfibrosisassociatedwithnonbacterialinfections
AT bossojohna clinicalmanifestationsofexacerbationsofcysticfibrosisassociatedwithnonbacterialinfections
AT turnerronaldb clinicalmanifestationsofexacerbationsofcysticfibrosisassociatedwithnonbacterialinfections